Department of Anatomy, Physiology and Pharmacology, College of Veterinary Medicine, Auburn University, Auburn, AL, USA.
Stress. 2021 Sep;24(5):659-666. doi: 10.1080/10253890.2021.1907340. Epub 2021 Apr 10.
Dexamethasone-induced Ras-related protein 1 (Rasd1) is a member of the Ras superfamily of monomeric G proteins that have a regulatory function in signal transduction. Rasd1, also known as Dexras1 or AGS1, is rapidly induced by dexamethasone (Dex). While prior data indicates that Rasd1 is highly expressed in the pituitary and that the gene may function in regulation of corticotroph activity, its exact cellular localization in this tissue has not been delineated. Nor has it been determined which endocrine pituitary cell type(s) are responsive to Dex-induced expression of Rasd1. We hypothesized that Rasd1 is primarily localized in corticotrophs and furthermore, that its expression in these cells would be upregulated in response to exogenous Dex administration. Rasd1 expression in each pituitary cell type both under basal conditions and 1-hour post Dex treatment were examined in adult male mice. While a proportion of all endocrine pituitary cell types expressed Rasd1, a majority of corticotrophs and thyrotrophs expressed Rasd1 under basal condition. In vehicle treated animals, approximately 50-60% of corticotrophs and thyrotrophs cells expressed Rasd1 while the gene was detected in only 15-30% of lactotrophs, somatotrophs, and gonadotrophs. In Dex treated animals, Rasd1 expression was significantly increased in corticotrophs, somatotrophs, lactotrophs, and gonadotrophs but not thyrotrophs. In Dex treated animals, Rasd1 was detected in 80-95% of gonadotrophs and corticotrophs. In contrast, Dex treatment increased Rasd1 expression to a lesser extent (55-60%) in somatotrophs and lactotrophs. Corticotrophs of the pars intermedia, which lack glucocorticoid receptors, failed to display increased Rasd1 expression in Dex treated animals. Rasd1 is highly expressed in corticotrophs under basal conditions and is further increased after Dex treatment, further supporting its role in glucocorticoid negative feedback. In addition, the presence and Dex-induced expression of Rasd1 in endocrine pituitary cell types, other than corticotrophs, may implicate Rasd1 in novel pituitary functions.
地塞米松诱导的 Ras 相关蛋白 1(Rasd1)是单体 G 蛋白 Ras 超家族的成员,在信号转导中具有调节功能。Rasd1,也称为 Dexras1 或 AGS1,可被地塞米松(Dex)快速诱导。尽管先前的数据表明 Rasd1 在垂体中高度表达,并且该基因可能在调节促肾上腺皮质激素活性中发挥作用,但它在该组织中的确切细胞定位尚未确定。也尚未确定哪种内分泌垂体细胞类型对 Dex 诱导的 Rasd1 表达有反应。我们假设 Rasd1 主要定位于促肾上腺皮质细胞中,此外,其在这些细胞中的表达将对外源 Dex 给药作出上调反应。在成年雄性小鼠中,在基础条件和 Dex 处理后 1 小时检查了每种垂体细胞类型中的 Rasd1 表达。虽然所有内分泌垂体细胞类型都表达了 Rasd1,但在基础条件下,大多数促肾上腺皮质细胞和甲状腺细胞都表达了 Rasd1。在载体处理的动物中,约 50-60%的促肾上腺皮质细胞和甲状腺细胞表达 Rasd1,而该基因仅在 15-30%的催乳素细胞、生长激素细胞和促性腺激素细胞中检测到。在 Dex 处理的动物中,Rasd1 在促肾上腺皮质细胞、生长激素细胞、催乳素细胞和促性腺激素细胞中的表达显著增加,但在甲状腺细胞中没有增加。在 Dex 处理的动物中,Rasd1 在 80-95%的促性腺激素细胞和促肾上腺皮质细胞中被检测到。相比之下,Dex 处理使生长激素细胞和催乳素细胞中的 Rasd1 表达增加的程度较小(55-60%)。缺乏糖皮质激素受体的中间部促肾上腺皮质细胞在 Dex 处理的动物中未能显示出 Rasd1 表达增加。Rasd1 在基础条件下在促肾上腺皮质细胞中高度表达,并且在 Dex 处理后进一步增加,这进一步支持了它在糖皮质激素负反馈中的作用。此外,Rasd1 在除促肾上腺皮质细胞以外的内分泌垂体细胞类型中的存在和 Dex 诱导表达可能暗示 Rasd1 在新的垂体功能中发挥作用。